CareSpeak, Molina raise medication adherence with texting

Molina Healthcare and CareSpeak Communications launched a text messaging platform to remind patients to take their medication.

Members will be able to receive personalized text reminders on medication therapy management to improve medication adherence, including even the most complex dosing regimens. They will also receive feedback from a pharmacist when their adherence levels fall below a certain level.

“All signs are pointing to mobile health becoming an important tool in the daily life of the chronically ill and their caregiver family members," said Serge Loncar, CEO of CareSpeak. “We are excited to be able to offer our user-friendly and clinically effective solution to Molina and their members.”

Molina will provide CareSpeak’s digital health platform to members in California, Michigan and Ohio, available in both English and Spanish.

“Molina’s mission is to provide quality health services to financially vulnerable families. Our members tend to be at greater risk for prescription medication errors and non-adherence. Digital technologies like the CareSpeak text messaging platform are affordable and scalable tools we can use in combination with our medication therapy management to better help our members manage their medications and avoid the unintended consequences of non-adherence," said Martha Molina Bernadett, MD, Chief Innovation Officer at Molina Healthcare.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup